Asia-Pacific Heparin Market – Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Published Report
  • Jul 2019
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 268
  • No of Figures: 33

Asia-Pacific Heparin Market By Product Type (Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra-Low Molecular Weight Heparin (ULMWH), Mode of Administration (Oral Administration, Parenteral  Administration), Source (Bovine, Porcine), Ingredients(Sodium, Calcium, Others), Availability (Raw, Processed), Treatment (Deep Vein Thrombosis, Pulmonary Embolism, Arterial Thromboembolism, Others), Application (Pre-Surgical Procedures, Post-Surgical Procedures, Kidney Dialysis, Diagnostic Tests, Others),  Therapeutics (Cardiovascular, Respiratory, Oncology, Nephrology, CNS, Others),  Strength (10 Unit, 100 Unit, 1000 Unit, 5000 Unit, 10000 Unit, 25000 Unit, Others),   Type (Generics, Brands),  Container (Bottles, Bags, Vials, Others),  Packaging (Glass, Plastic),  End User (Hospitals, Clinics, Homecare, Ambulatory Surgical Centres, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy & Drug Store, Online Pharmacy, Others), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, rest of Asia-Pacific) – Industry Trends and Forecast to 2026

Heparin is medication is used to prevent and treat blood clots. It is used to treat blood clotting disorders. It is also used to prevent blood clots after surgery, during blood transfusions, dialysis, and blood samples. It helps in smooth blood flowing by releasing anti-clotting protein. It is known as an anticoagulant. It is also used in diagnose and treatment of disseminated intravascular coagulation, deep vein thrombosis, pulmonary embolism, and arterial thromboembolism. It cannot dissolve blood clots but only prevent the clots from becoming larger and causing more serious problems. Heparin is an animal-derived product, derived from mucosal tissues of slaughtered meat animals.

Heparin is used for Diagnosis of heart attacks and unstable angina, Inhibition of cancer, metabolic disorders, and hepatitis, as an anti-inflammatory drug in injuries as Anti-Coagulants in blood sampling.

Asia-Pacific heparin market is projected to register a substantial CAGR in the forecast period of 2019 to 2026.

Segmentation: Asia-Pacific Heparin Market

Asia-Pacific heparin market is segmented into fourteen notable segments which are product type, mode of administration, source, ingredients, availability, treatment, application, therapeutics, strength, brands, type, container, packaging, end user, distribution channel. 

  • On the basis of product type, the market is segmented into unfractionated heparin, low molecular weight heparin (LMWH) and ultra-low molecular weight heparin (ULMWH)
  • On the basis of mode of administration, the market is segmented into oral administration and parenteral administration
  • On the basis of source, the market is segmented into bovine and porcine
  • On the basis of ingredients, the market is segmented into sodium and calcium and others
  • On the basis of availability, the market is segmented into raw, and processed
  • On the basis of treatment, the market is segmented into deep vein thrombosis, pulmonary embolism, arterial thromboembolism and others
  • On the basis of application, the market is segmented into pre-surgical procedures, post-surgical procedures, kidney dialysis, diagnostic tests and others
  • On the basis of therapeutics, the market is segmented into cardiovascular, respiratory, oncology, nephrology, CNS and others
  • On the basis of strength, the market is segmented into 10 unit, 100 unit, 1000 unit, 5000 unit, 10000 unit, 25000 unit and others
  • On the basis of type, the market is segmented into generics and brands
  • On the basis of container, the market is segmented into bottles, bags, vials and others
  • On the basis of packaging, the market is segmented into glass and plastic
  • On the basis of end user, the market is segmented into hospitals, clinics, homecare, ambulatory surgical centers and others
  • On the basis of distribution channel, the market is segmented into hospital pharmacy, retail pharmacy & drug store, online pharmacy and others

Competitive Analysis: Asia-Pacific Heparin Market

Some of the major players operating in this market are Sanofi, Pfizer Inc, F. Hoffmann-La Roche Ltd , Mylan N.V., Aspen Holdings, Changzhaou Qianhong Bio-pharma Co., ltd., Eisai Co., Ltd., Fresenius Kabi AG, Hebei Changshan Biochemical Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, LEO Pharma A/S, Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd., Novartis AG, OPOCRIN S.P.A, SARIA SE & Co. KG, Shanghai Fosun Pharmaceutical (Group) Co., Ltd, Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Techdow Pharmaceutical Co., Ltd, Teva Pharmaceutical Industries Ltd., Yino Pharma Limited, and among others

Recent Developments:

  • In 2019 Aspen Holding has transferred manufactures of Fraxiparine and Mono-embolex vials to Port Elizabeth site. Transfer of Mono-embolex prefilled syringes to its Notre Dame de Bondeville site. The main purpose of this transfer is to enhance the production capacity.  
  • In May 2018, Changzhou Qianhong Bio-pharma Co.,Ltd., a leading biochemical maker of polysaccharides and enzyme drugs has initiated the construction on phase two of its pharmaceuticals production. The company invested USD 146 million for the production of 200 million tablets and 60 million injections as well as making molecular diagnosis. This investment will help the company in expanding its business for the treatment of critical illness like cancer, cardiovascular and cerebrovascular diseases.
  • In 2015 Hebei changshan biochemical pharmaceutical co. Ltd. attained 2015 CPHI Shanghai in China. CPHI is the most comprehensive pharmaceutical exhibition in Asia it provides information of market trends and technical innovations in the entire industry. The main purpose of this conference is to highlight the product and expand the business.

Research Methodology: Asia-Pacific Heparin Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturers, Researchers, Distributors and Pharmacologist, Industrialists.

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.


SKU-

TABLE 1 ASIA-PACIFIC HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 2 ASIA-PACIFIC UNFRACTIONATED HEPARIN IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 3 ASIA-PACIFIC LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 4 ASIA-PACIFIC LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2016-2026 (USD MILLION)

TABLE 5 ASIA-PACIFIC ULTRA LOW MOLECULAR WEIGHT HEPARIN (ULMWH) IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 6 ASIA-PACIFIC ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) IN HEPARIN MARKET, BY TYPE, 2016-2026 (USD MILLION)

TABLE 7 ASIA-PACIFIC HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 8 ASIA-PACIFIC ORAL IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 ASIA-PACIFIC PARENTERAL ADMINISTRATION IN HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2016-2026 (USD MILLION)

TABLE 10 ASIA-PACIFIC PARENTRAL IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 ASIA-PACIFIC HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 12 ASIA-PACIFIC BOVINE IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 ASIA-PACIFIC PORCINE IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 14 ASIA-PACIFIC HEPARIN MARKET, BY INGREDIENTS, 2016-2026 (USD MILLION)

TABLE 15 ASIA-PACIFIC SODIUM IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 16 ASIA-PACIFIC CALCIUM IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 ASIA-PACIFIC OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 18 ASIA-PACIFIC HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 19 ASIA-PACIFIC RAW IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 20 TABLE1 ASIA-PACIFIC PROCESSED IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 ASIA-PACIFIC HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 22 ASIA-PACIFIC DEEP VEIN THROMBOSIS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 ASIA-PACIFIC PULMONARY EMBOLISM IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 24 ASIA-PACIFIC ARTERIAL THROMBOEMBOLISM IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 25 ASIA-PACIFIC OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 ASIA-PACIFIC HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 27 ASIA-PACIFIC PRE-SURGICAL PROCEDURES IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 ASIA-PACIFIC POST-SURGICAL PROCEDURES IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 ASIA-PACIFIC KIDNEY DIALYSIS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 ASIA-PACIFIC DIAGNOSTIC TEST IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 ASIA-PACIFIC OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 ASIA-PACIFIC HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 33 ASIA-PACIFIC CARDIOVASCULAR IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 ASIA-PACIFIC RESPIRATORY IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 ASIA-PACIFIC ONCOLOGY IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 36 ASIA-PACIFIC NEPHROLOGY IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 37 ASIA-PACIFIC CNS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 38 ASIA-PACIFIC OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 39 ASIA-PACIFIC HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 40 ASIA-PACIFIC 10 UNITS IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 41 ASIA-PACIFIC 100 UNIT IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 42 ASIA-PACIFIC 1000 UNITS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 43 ASIA-PACIFIC 5000 UNITS IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 44 ASIA-PACIFIC 10000 UNITS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 45 ASIA-PACIFIC 25000 UNITS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 46 ASIA-PACIFIC OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 47 ASIA-PACIFIC GENERICS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 48 ASIA-PACIFIC HEPARIN MARKET, BY BRANDED, 2017-2026 (USD MILLION)

TABLE 49 ASIA-PACIFIC BRANDEDS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 50 ASIA-PACIFIC HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 51 ASIA-PACIFIC BOTTLES IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 52 ASIA-PACIFIC BAGS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 53 ASIA-PACIFIC VIALS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 55 ASIA-PACIFIC HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 56 ASIA-PACIFIC GLASS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 57 ASIA-PACIFIC PLASTIC IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 58 ASIA-PACIFIC HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 59 ASIA-PACIFIC HOSPITALS IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 60 ASIA-PACIFIC CLINICS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 61 ASIA-PACIFIC HOMECARE IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 62 ASIA-PACIFIC AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 63 ASIA-PACIFIC OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 64 ASIA-PACIFIC HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 65 ASIA-PACIFIC HOSPITAL PHARMACY IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 66 ASIA-PACIFIC RETAIL PHARMACY & DRUG STORE IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 67 ASIA-PACIFIC ONLINE PHARMACY IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 68 ASIA-PACIFIC OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 69 ASIA-PACIFIC HEPARIN MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 70 ASIA-PACIFIC HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 71 ASIA-PACIFIC LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 72 ASIA-PACIFIC ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 73 ASIA-PACIFIC HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2016-2026 (USD MILLION)

TABLE 74 ASIA-PACIFIC PARENTERAL ADMINISTRATION IN HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2016-2026 (USD MILLION)

TABLE 75 ASIA-PACIFIC HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 76 ASIA-PACIFIC HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 77 ASIA-PACIFIC HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 78 ASIA-PACIFIC HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 79 ASIA-PACIFIC HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 80 ASIA-PACIFIC HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 81 ASIA-PACIFIC HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 82 ASIA-PACIFIC HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 83 ASIA-PACIFIC BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 84 ASIA-PACIFIC HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 85 ASIA-PACIFIC HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 86 ASIA-PACIFIC HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 87 ASIA-PACIFIC HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 88 JAPAN HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 89 JAPAN LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 90 JAPAN ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 91 JAPAN HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 92 JAPAN PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 93 JAPAN HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 94 JAPAN HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 95 JAPAN HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 96 JAPAN HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 97 JAPAN HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 98 JAPAN HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 99 JAPAN HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 100 JAPAN HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 101 JAPAN BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 102 JAPAN HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 103 JAPAN HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 104 JAPAN HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 105 JAPAN HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 106 CHINA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 107 CHINA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 108 CHINA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 109 CHINA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 110 CHINA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 111 CHINA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 112 CHINA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 113 CHINA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 114 CHINA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 115 CHINA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 116 CHINA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 117 CHINA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 118 CHINA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 119 CHINA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 120 CHINA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 121 CHINA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 122 CHINA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 123 CHINA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 124 SOUTH KOREA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 125 SOUTH KOREA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 126 SOUTH KOREA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 127 SOUTH KOREA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 128 SOUTH KOREA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 129 SOUTH KOREA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 130 SOUTH KOREA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 131 SOUTH KOREA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 132 SOUTH KOREA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 133 SOUTH KOREA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 134 SOUTH KOREA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 135 SOUTH KOREA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 136 SOUTH KOREA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 137 SOUTH KOREA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 138 SOUTH KOREA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 139 SOUTH KOREA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 140 SOUTH KOREA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 141 SOUTH KOREA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 142 INDIA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 143 INDIA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 144 INDIA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 145 INDIA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 146 INDIA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 147 INDIA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 148 INDIA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 149 INDIA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 150 INDIA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 151 INDIA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 152 INDIA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 153 INDIA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 154 INDIA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 155 INDIA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 156 INDIA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 157 INDIA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 158 INDIA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 159 INDIA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 160 AUSTRALIA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 161 AUSTRALIA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 162 AUSTRALIA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 163 AUSTRALIA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 164 AUSTRALIA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 165 AUSTRALIA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 166 AUSTRALIA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 167 AUSTRALIA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 168 AUSTRALIA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 169 AUSTRALIA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 170 AUSTRALIA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 171 AUSTRALIA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 172 AUSTRALIA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 173 AUSTRALIA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 174 AUSTRALIA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 175 AUSTRALIA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 176 AUSTRALIA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 177 AUSTRALIA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 178 SINGAPORE HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 179 SINGAPORE LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 180 SINGAPORE ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 181 SINGAPORE HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 182 SINGAPORE PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 183 SINGAPORE HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 184 SINGAPORE HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 185 SINGAPORE HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 186 SINGAPORE HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 187 SINGAPORE HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 188 SINGAPORE HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 189 SINGAPORE HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 190 SINGAPORE HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 191 SINGAPORE BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 192 SINGAPORE HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 193 SINGAPORE HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 194 SINGAPORE HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 195 SINGAPORE HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 196 PHILIPPINES HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 197 PHILIPPINES LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 198 PHILIPPINES ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 199 PHILIPPINES HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 200 PHILIPPINES PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 201 PHILIPPINES HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 202 PHILIPPINES HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 203 PHILIPPINES HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 204 PHILIPPINES HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 205 PHILIPPINES HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 206 PHILIPPINES HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 207 PHILIPPINES HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 208 PHILIPPINES HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 209 PHILIPPINES BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 210 PHILIPPINES HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 211 PHILIPPINES HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 212 PHILIPPINES HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 213 PHILIPPINES HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 214 INDONESIA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 215 INDONESIA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 216 INDONESIA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 217 INDONESIA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 218 INDONESIA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 219 INDONESIA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 220 INDONESIA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 221 INDONESIA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 222 INDONESIA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 223 INDONESIA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 224 INDONESIA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 225 INDONESIA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 226 INDONESIA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 227 INDONESIA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 228 INDONESIA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 229 INDONESIA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 230 INDONESIA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 231 INDONESIA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 232 THAILAND HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 233 THAILAND LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 234 THAILAND ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 235 THAILAND HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 236 THAILAND PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 237 THAILAND HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 238 THAILAND HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 239 THAILAND HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 240 THAILAND HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 241 THAILAND HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 242 THAILAND HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 243 THAILAND HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 244 THAILAND HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 245 THAILAND BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 246 THAILAND HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 247 THAILAND HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 248 THAILAND HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 249 THAILAND HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 250 MALAYSIA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 251 MALAYSIA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 252 MALAYSIA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 253 MALAYSIA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 254 MALAYSIA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 255 MALAYSIA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 256 MALAYSIA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 257 MALAYSIA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 258 MALAYSIA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 259 MALAYSIA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 260 MALAYSIA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 261 MALAYSIA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 262 MALAYSIA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 263 MALAYSIA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 264 MALAYSIA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 265 MALAYSIA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 266 MALAYSIA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 267 MALAYSIA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 268 REST OF APAC HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19